MoneyWorks4Me

Mangalam Drugs & Organics informs about compliances-certificate

25 Jul 2023 Evaluate
In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended from time to time, Mangalam Drugs & Organics has informed that it attached the Compliance Certificate as received from ‘Link Intime India’ Registrar and Share Transfer Agent of the Company for the quarter ended June 30, 2023.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..